English  |  正體中文  |  简体中文  |  总笔数 :2822924  
造访人次 :  30036089    在线人数 :  1235
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"lin l i"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 276-300 / 401 (共17页)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-04-10T12:51:11Z Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway Ou D.-L.; Lee B.-S.; Chang Y.-C.; Lin L.-I.; Liou J.-Y.; Chiun Hsu; Cheng A.-L.
臺大學術典藏 2020-04-10T12:51:08Z Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin Ou D.-L.;Lee B.-S.;Lin L.-I.;Liou J.-Y.;Liao S.-C.;Chiun Hsu;Cheng A.-L.; Ou D.-L.; Lee B.-S.; Lin L.-I.; Liou J.-Y.; Liao S.-C.; Chiun Hsu; Cheng A.-L.
臺大學術典藏 2020-04-10T12:51:06Z Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma Ou D.-L.;Shyue S.-K.;Lin L.-I.;Feng Z.-R.;Liou J.-Y.;Fan H.-H.;Lee B.-S.;Chiun Hsu;Cheng A.-L.Ann-Lii; Ou D.-L.; Shyue S.-K.; Lin L.-I.; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; Chiun Hsu; Cheng A.-L.Ann-Lii
臺大學術典藏 2020-04-10T12:51:06Z H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; Ou D.-L.; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; Chiun Hsu; Lin L.-I.; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y.
臺大學術典藏 2020-04-10T12:51:03Z Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression Chiun Hsu; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; Shao Y.-Y.; Cheng A.-L.; Ou D.-L.
臺大學術典藏 2020-04-10T12:16:01Z Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression Hsu C.; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; YU-YUN SHAO; Cheng A.-L.; Ou D.-L.
臺大學術典藏 2020-03-30T03:55:55Z Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases Lin L.-I.; Lin K.-S.; Chang J.-S.; Lin D.-T.; Lin Tsai S.-J.; SHYH-CHYI LO; Pai S.-C.; Pai S.-C.;Shyh-Chyi Lo;Lin Tsai S.-J.;Chang J.-S.;Lin D.-T.;Lin K.-S.;Lin L.-I.
臺大學術典藏 2020-03-07T06:56:33Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏 2020-03-07T06:56:33Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-07T06:56:25Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏 2020-03-07T06:56:23Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-07T06:56:18Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.
臺大學術典藏 2020-03-07T06:42:09Z Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression Huang H.-N.;Lin M.-C.;Tseng L.-H.;Chiang Y.-C.;Lin L.-I.;Lin Y.-F.;Huang H.-Y.;Kuan-Ting Kuo; Huang H.-Y.; KUAN-TING KUO; Lin L.-I.; Lin Y.-F.; Chiang Y.-C.; Tseng L.-H.; Lin M.-C.; Huang H.-N.
臺大學術典藏 2020-03-06T08:25:04Z Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis Cheng Y.-C.; Cheng M.-L.; YUNG-MING JENG; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Lin L.-I.
臺大學術典藏 2020-03-06T08:25:01Z Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Liau J.-Y.;Yung-Ming Jeng; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; YUNG-MING JENG
臺大學術典藏 2020-03-06T08:24:55Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; YUNG-MING JENG
臺大學術典藏 2020-03-06T05:26:20Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T05:26:15Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T05:26:12Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-06T05:26:09Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T12:22:25Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T12:22:25Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.
臺大學術典藏 2020-03-05T07:52:33Z Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression Huang H.-N.; Lin M.-C.; Tseng L.-H.; Chiang Y.-C.; Lin L.-I.; Lin Y.-F.; Huang H.-Y.; KUAN-TING KUO
臺大學術典藏 2020-03-05T07:31:48Z Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M.
臺大學術典藏 2020-03-05T07:31:48Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.

显示项目 276-300 / 401 (共17页)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每页显示[10|25|50]项目